univadis

MSD Signs Partnership With BMJ Group





BERLIN, June 17 /PRNewswire/ --

- univadis(R) Users Gain Access to BMJ Learning Content for CME and CPD

    The pharmaceutical company MSD (known as Merck Sharp & Dohme Limited in
the UK and Merck & Co., Inc. in the US) and BMJ (British Medical Journal)
Group today announced a partnership in medical education through which BMJ
Learning will be made available to physicians through MSD's medical portal
univadis(R). This unique partnership will change the face of medical
education in Europe and beyond, allowing users access to most of BMJ
Learning's library of 'Continuing Medical Education' (CME) and 'Continuing
Professional Development' (CPD) content. The agreement between MSD and BMJ
Group comprises about 350 interactive learning courses in over 20 medical
therapy areas. The partnership will allow physicians to combine online
CME/CPD and offline learning.



    univadis(R) (http://www.univadis.com), one of the leading medical
Internet services in Europe, the Middle East, Africa and Canada with more
than half a million registered physicians, is a pioneer in medical education,
meeting the need for high-quality accredited education for physicians,
enabling them to better manage their patients and their outcomes. In addition
to the educational offer, univadis(R) provides a number of tailored medical
information sources based on continuous needs assessment of healthcare
professionals. univadis(R) will start to cover a growing number of combined
online and offline training programmes, making medical education more
effective.



    BMJ Learning is one of the world's largest and most trusted independent
online learning and course providers for medical professionals. BMJ Group is
dedicated to the expansion of BMJ Learning with new peer-reviewed and
evidence-based courses launching every week.



    This partnership with univadis(R) will play a crucial role in opening the
gateway for physicians into BMJ Learning. "BMJ Learning is already used by
82,000 doctors in the UK and this partnership will enable doctors in many
different countries to benefit from BMJ Group's expertise in medical
education," says Michael Chamberlain, Chairman of BMJ Group.



    Dr. Ottfried Zierenberg, Regional Medical Director Europe, Middle East,
Africa & Canada of MSD, commented "We chose to work with the BMJ Group
because they are one of the most respected medical courses providers, making
them a perfect partner for us. This collaboration intends to ultimately
increase the health outcome for patients. Additionally, it strengthens the
position of univadis(R) as a trusted, professional and comprehensive news,
information and educational resource for the medical community".



    BMJ Learning online courses will be available on univadis(R) in English
language in English speaking countries, i.e. UK and Ireland, as well as in
Scandinavian countries beginning June 2008. Other countries, like Germany,
will follow within 2008 once the translation process is finished.



About MSD

    Merck Sharp & Dohme Limited (MSD) is the UK subsidiary of Merck & Co.,
Inc., of Whitehouse Station, New Jersey, USA, a leading research-based
pharmaceutical company that discovers, develops, manufactures and markets a
wide range of innovative pharmaceutical products to improve human health.



About BMJ Group

    BMJ Group is one of the world's leading providers of trusted medical
information for healthcare professionals and patients. BMJ Group provides
through BMJ Learning, continuing professional development online modules and
exam revision materials, as well as events and workshops for the healthcare
profession. The Group is well known for publishing the BMJ (British Medical
Journal), over 25 specialist journals, BMJ Clinical Evidence and BMJ Best
Treatments (currently available in the UK from AskBoots.com). BMJ Group is
owned by the British Medical Association. It is editorially independent and
the articles and content it publishes are not intended to reflect BMA policy.